Condition: Chemotherapy-induced Polyneuropathy · Sponsor: WALA Heilmittel GmbH
The clinical trial is planned as a prospective, multicentre, blinded, randomised, placebo-controlled, national clinical trial in Germany. The clinical trial is designed for testing the prophylactic and therapeutic effects of Aconite pain oil as compared to placebo in oncological patients receiving neurotoxic chemotherapy with taxanes and/or platinum derivatives.
This description comes directly from the study's public registry record.
Florian Stintzing, Prof. Dr. · klin-pruef-klifo@wala.de
Always discuss trial participation with your own doctor first.
| Medizinische Fakultät Mannheim der Uniklinik Heidelberg | Mannheim, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06186479